Market Closed

SPRY
ARS Pharmaceuticals
$ 3.89
2.10%   Last 24H
 
Trading with leverage comes with a high risk and may not be suitable for everyone.
   
Trading with leverage comes with a high risk and may not be suitable for everyone.
Portfolio
Updated 2 days ago

ARS Pharmaceuticals News

Latest ARS Pharmaceuticals Stock News & SPRY Headlines

CenterBook Partners LP Buys 295,532 Shares of ARS Pharmaceuticals, Inc. $SPRY
7 days ago | defenseworld.net
ARS Pharmaceuticals Analysts Cut Their Forecasts After Downbeat Q3 Results
10 days ago | benzinga.com
ARS Pharmaceuticals, Inc. (SPRY) Q3 2026 Earnings Call Transcript
10 days ago | seekingalpha.com
ARS Pharmaceuticals Q3 Earnings Call Highlights
10 days ago | marketbeat.com
ARS Pharmaceuticals, Inc. (SPRY) Reports Q3 Loss, Lags Revenue Estimates
10 days ago | zacks.com
ARS Pharmaceuticals: Lawsuits And Cash Burn Are Priced In, Yet The Stock Keeps Falling
13 days ago | seekingalpha.com
ARS Pharmaceuticals, Inc. (SPRY) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
18 days ago | zacks.com
ARS Pharma to Report Third Quarter 2026 Financial Results
18 days ago | globenewswire.com
SPRY Investors Have Opportunity to Lead ARS Pharmaceuticals, Inc. Securities Fraud Lawsuit with SBS Law
a month ago | gurufocus.com
SPRY FINAL DEADLINE ALERT: Faruqi & Faruqi, LLP Reminds ARS Pharmaceuticals Investors of Securities Class Action Lawsuit Deadline on October 5, 2026
a month ago | businesswire.com
Load More

Download App

Keep track of your holdings and explore over 40,000 cryptocurrencies

oinCodex Android App
CoinCodex Mobile App
Market Closed

SPRY
ARS Pharmaceuticals
$ 3.89
2.10%   Last 24H
 
Trading with leverage comes with a high risk and may not be suitable for everyone.
   
Trading with leverage comes with a high risk and may not be suitable for everyone.
Portfolio
Updated 2 days ago